FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Tuned Raises $2.5M Seed Round to Radically Upend the Status Quo in Hearing Care
Tuned advised the funding was led by Idealab NY and Elements Health Ventures.
CoverSelf Secures $4.8M to Reinvent Healthcare Claims and Payment Accuracy as It Expands in the US
CoverSelf is helping healthcare stakeholders by ensuring the acceleration of accurate healthcare claims and reduction of administrative waste.
Ontogen Medtech Awarded $258k Phase I SBIR Grant From The NIH To Develop Innovative Pulmonary Embolism Catheter
The proposed novel catheter design, developed in collaboration with Flow Medical, improves upon current catheter-directed thrombolysis (CDT) treatment methods to improve patient outcomes and optimize the physician experience notes Ontogen Medtech.
Hexarad Completes Series A Funding – Raises Additional £2.2 Million
The additional funding raised through this round will allow Hexarad to continue to grow its radiology platform which focuses on allocative efficiency to improve scan reporting times.
German Federal Ministry of Education and Research Awards Grants to Gund a Clinical Trial for LISA Laser Innovated “Novel Treatment of Urolithiasis”
Urolithiasis is a common disease affecting about 12% of the global population. Consequently, urolithiasis is a widespread disease with significant socioeconomic impact and is relevant to healthcare in terms of society and health policy.
American Injectables Announces Validation of its Tampa Operations
American Injectables is now well positioned to help fill the gap in US-based manufacturing of sterile injectables to alleviate current drug shortages.
Theranica Secures $45 Million Series C Funding Round
Theranica advises the proceeds will fund the U.S. commercial expansion of migraine treatment device , Nerivio®
Avenda Health Raises $10M in Series B
Avenda Health notes the capital will be used to accelerate the use of iQuest, an AI-enabled patient management software that identifies and visualizes a patient's prostate cancer. The funding will also be used to continue clinical evidence development.
Levee Medical Reports Closing of $6.6 Series A Financing
Levee Medical notes the funds will be used to advance product development, scale infrastructure, and expand the team to support the development of the company’s Voro Urologic Scaffold, a bioresorbable post-prostatectomy implant.
Medical Device News Magazine
